Stockscreener 앱 받기
3.37
1.20%
0.04
시간 외 거래:
3.31
-0.06
-1.78%
전일 마감가:
$3.33
열려 있는:
$3.36
하루 거래량:
141.59K
Relative Volume:
0.39
시가총액:
$267.43M
수익:
$351.37M
순이익/손실:
$-174.01M
주가수익비율:
-1.628
EPS:
-2.07
순현금흐름:
$-126.94M
1주 성능:
+0.30%
1개월 성능:
-4.26%
6개월 성능:
+11.96%
1년 성능:
-6.91%
1일 변동 폭
$3.285
$3.405
1주일 범위
$3.285
$3.47
52주 변동 폭
$2.455
$4.145
Atea Pharmaceuticals Inc Stock (AVIR) Company Profile
명칭
Atea Pharmaceuticals Inc
전화
857-204-8109
주소
225 FRANKLIN STREET, BOSTON
AVIR을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
AVIR
Atea Pharmaceuticals Inc
|
3.37 | 264.26M | 351.37M | -174.01M | -126.94M | -2.07 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Atea Pharmaceuticals Inc Stock (AVIR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-08-13 | 업그레이드 | Morgan Stanley | Underweight → Equal-Weight |
| 2023-08-10 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2022-01-06 | 다운그레이드 | Morgan Stanley | Equal-Weight → Underweight |
| 2021-11-18 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform |
| 2021-10-20 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2021-10-05 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2020-11-25 | 개시 | Evercore ISI | Outperform |
| 2020-11-24 | 개시 | JP Morgan | Overweight |
| 2020-11-24 | 개시 | Morgan Stanley | Overweight |
| 2020-11-24 | 개시 | William Blair | Outperform |
모두보기
Atea Pharmaceuticals Inc 주식(AVIR)의 최신 뉴스
Does Atea Pharmaceuticals Inc. offer margin of safetyJuly 2025 Highlights & High Accuracy Investment Signals - خودرو بانک
American Century Companies Inc. Purchases 17,666 Shares of Atea Pharmaceuticals, Inc. $AVIR - Defense World
Will Atea Pharmaceuticals Inc. outperform its industry peersPortfolio Value Summary & Growth-Oriented Investment Plans - خودرو بانک
What are Atea Pharmaceuticals Inc.’s earnings expectationsJuly 2025 Sentiment & Verified Entry Point Detection - خودرو بانک
Does Atea Pharmaceuticals Inc. qualify in momentum factor screeningJuly 2025 Short Interest & Low Risk High Reward Ideas - Newser
Evaluating Atea Pharmaceuticals Inc. with trendline analysisWall Street Watch & Expert Curated Trade Setups - Newser
Will Atea Pharmaceuticals Inc. announce a stock split2025 Trading Volume Trends & Weekly Hot Stock Watchlists - خودرو بانک
Building trade automation scripts for Atea Pharmaceuticals Inc.Fed Meeting & Technical Confirmation Alerts - Newser
What Fibonacci levels say about Atea Pharmaceuticals Inc. reboundAnalyst Upgrade & Advanced Swing Trade Entry Plans - Newser
Atea Pharmaceuticals’ Earnings Call Highlights HCV Progress - MSN
Signal strength of Atea Pharmaceuticals Inc. stock in tech scannersJuly 2025 Institutional & Fast Entry and Exit Trade Plans - Newser
Does Atea Pharmaceuticals Inc. have strong fundamentals2025 Fundamental Recap & Weekly Breakout Watchlists - خودرو بانک
What momentum shifts mean for Atea Pharmaceuticals Inc.Weekly Profit Analysis & Fast Entry Momentum Alerts - Newser
Should you hold or exit Atea Pharmaceuticals Inc. now2025 AllTime Highs & Intraday High Probability Alerts - Newser
What is the earnings history of Atea Pharmaceuticals Inc.July 2025 Chart Watch & High Conviction Buy Zone Picks - خودرو بانک
How institutional ownership impacts Atea Pharmaceuticals Inc. stockTrade Risk Report & Target Return Focused Stock Picks - Newser
Multi factor analysis applied to Atea Pharmaceuticals Inc.2025 Momentum Check & Fast Moving Stock Trade Plans - Newser
Predicting Atea Pharmaceuticals Inc. trend using moving averagesTrend Reversal & Daily Technical Forecast Reports - Newser
Will Atea Pharmaceuticals Inc. price bounce be sustainableJuly 2025 Action & Daily Profit Focused Stock Screening - Newser
Analyzing Atea Pharmaceuticals Inc. with risk reward ratio chartsCEO Change & Safe Capital Preservation Plans - Newser
How cyclical is Atea Pharmaceuticals Inc.’s revenue streamGold Moves & Weekly Breakout Watchlists - خودرو بانک
Atea Pharmaceuticals Inc. stock daily chart insightsWeekly Profit Report & Weekly Breakout Opportunity Watchlist - Newser
Is Atea Pharmaceuticals Inc. meeting your algorithmic filter criteriaStock Surge & Risk Adjusted Buy/Sell Alerts - Newser
Is Atea Pharmaceuticals Inc. trending in predictive chart modelsEntry Point & Technical Pattern Alert System - Newser
What dividend growth rate does Atea Pharmaceuticals Inc. offer2025 Top Gainers & Stock Portfolio Risk Control - خودرو بانک
What technical models suggest about Atea Pharmaceuticals Inc.’s comebackCEO Change & Daily Entry Point Alerts - Newser
Using data tools to time your Atea Pharmaceuticals Inc. exitWeekly Market Outlook & Free Real-Time Volume Trigger Notifications - Newser
Can volume confirm reversal in Atea Pharmaceuticals Inc.July 2025 Short Interest & AI Enhanced Trade Execution Alerts - Newser
Is it too late to sell Atea Pharmaceuticals Inc.Trade Ideas & Capital Efficient Trading Techniques - Newser
Nuveen LLC Buys Shares of 291,091 Atea Pharmaceuticals, Inc. $AVIR - Defense World
Volatility clustering patterns for Atea Pharmaceuticals Inc.2025 Market Outlook & Reliable Breakout Forecasts - Newser
Short interest data insights for Atea Pharmaceuticals Inc.2025 Trading Recap & Free Daily Entry Point Trade Alerts - Newser
Will Atea Pharmaceuticals Inc. benefit from macro trendsEarnings Beat & Weekly Watchlist of Top Performers - Newser
Russell Investments Group Ltd. Purchases 54,398 Shares of Atea Pharmaceuticals, Inc. $AVIR - Defense World
How to monitor Atea Pharmaceuticals Inc. with trend dashboardsJuly 2025 EndofMonth & Free Low Drawdown Momentum Trade Ideas - Newser
What to do if you’re stuck in Atea Pharmaceuticals Inc.Weekly Trade Summary & Technical Pattern Based Signals - Newser
what’s next for atea pharmaceuticals inc. stock price2025 Price Targets & Precise Trade Entry Recommendations - Newser
Is Atea Pharmaceuticals Inc. likely to announce a buybackGlobal Markets & Stepwise Trade Signal Implementation - خودرو بانک
Atea Pharmaceuticals to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference - GlobeNewswire
Will Atea Pharmaceuticals Inc. outperform tech stocksJuly 2025 Technicals & Entry Point Confirmation Alerts - خودرو بانک
Atea Pharmaceuticals: Redefining Antiviral Therapeutics Through Strategic Innovation - AInvest
Antiviral Drug Developer Atea Pharmaceuticals to Present Latest Pipeline Updates at Morgan Stanley Conference - Stock Titan
How sensitive is Atea Pharmaceuticals Inc. to inflation2025 Buyback Activity & Smart Swing Trading Techniques - خودرو بانک
What’s next for Atea Pharmaceuticals Inc. stock priceBuy Signal & Fast Gain Swing Alerts - Newser
Atea Pharmaceuticals Inc (AVIR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Atea Pharmaceuticals Inc 주식 (AVIR) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| BERGER FRANKLIN M | Director |
Jun 20 '25 |
Option Exercise |
0.00 |
29,600 |
0 |
506,497 |
| Duncan Barbara Gayle | Director |
Jun 20 '25 |
Option Exercise |
0.00 |
29,600 |
0 |
62,750 |
| Polsky Bruce | Director |
Jun 20 '25 |
Option Exercise |
0.00 |
29,600 |
0 |
95,206 |
| Adams Jerome M. | Director |
Jun 20 '25 |
Option Exercise |
0.00 |
29,600 |
0 |
62,750 |
| Lucidi Bruno | Director |
Jun 20 '25 |
Option Exercise |
0.00 |
29,600 |
0 |
112,750 |
| BERGER FRANKLIN M | Director |
Dec 10 '24 |
Sale |
2.85 |
359,606 |
1,023,475 |
451,897 |
1.40%
자본화:
|
볼륨(24시간):